SPAZO2 (SOGUG): Validation of the international metastatic database consortium (IMDC) prognostic classification for targeted therapies as 2nd-line after 1st-line pazopanib (1stPz) in metastatic renal cell carcinoma (mRC)
Por:
Perez-Valderrama, B, Arija, J, Gonzalez, I, Herranz, U, Garcia, J, Rodriguez, C, Carbonero, I, de Velasco, G, Dominguez, R, Marrero, R, Baamonde, M, Palau, C, Lazaro, M, Munoz-Langa, J, Ortega, E, Jorge, A, Guillaumes, M, Moyano, M, Caro, R and Sanchez, A
Publicada:
1 sep 2017
Resumen:
Filiaciones:
Perez-Valderrama, B:
HH Virgen del Rocio, Med Oncol, Seville, Spain
Arija, J:
Hosp Gen Univ Gregorio Maranon, Med Oncol, Madrid, Spain
Gonzalez, I:
Hosp Clin Univ Valencia, Med Oncol, Valencia, Spain
Herranz, U:
Hosp Clin Univ Santiago de Compostela, Med Oncol, Santiago De Compostela, Spain
Garcia, J:
Hosp Clinico San Cecilio, Med Oncol, Granada, Spain
Rodriguez, C:
Vall dHebron Univ Hosp, Med Oncol, Barcelona, Spain
Carbonero, I:
Hosp Virgen de la Salud, Med Oncol, Toledo, Spain
de Velasco, G:
Hosp 12 Octubre, Med Oncol, Madrid, Spain
Dominguez, R:
Hosp Univ Salamanca, Med Oncol, Salamanca, Spain
Marrero, R:
Hosp Univ Canarias, Med Oncol, Santa Cruz De Tenerife, Spain
Baamonde, M:
Hosp Univ Son Espases, Med Oncol, Palma De Mallorca, Spain
Palau, C:
Hosp Univ Dr Peset, Med Oncol, Valencia, Spain
Lazaro, M:
Hosp Univ Alvaro Cunqueiro, Med Oncol, Vigo, Spain
:
Hosp Univ & Politecn La Fe, Med Oncol, Valencia, Spain
Ortega, E:
Univ Jaen, Med Oncol, Complejo Hosp Jaen, Jaen, Spain
Jorge, A:
Onkologikoa, Med Oncol, Donostia San Sebastian, Spain
Guillaumes, M:
Hosp Mutua Terrassa, Med Oncol, Terrassa, Spain
Moyano, M:
Hosp Infanta Sofia, Med Oncol, Madrid, Spain
Caro, R:
Hosp Virgen De Las Nieves, Med Oncol, Granada, Spain
Sanchez, A:
Complejo Asistencial Univ Leon, Med Oncol, Leon, Spain
|